Literature DB >> 20110558

Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease.

Ho Cheol Kim1, Mahroo Mofarrahi, Theodoros Vassilakopoulos, Francois Maltais, Ioanna Sigala, Richard Debigare, Ioannis Bellenis, Sabah N A Hussain.   

Abstract

RATIONALE: Nicotinamide N-methyl transferase (NNMT) is highly expressed in quadriceps muscles of patients with chronic obstructive pulmonary disease (COPD). However, its expression in the diaphragm of these patients has not been assessed. The functional significance of NNMT induction in skeletal muscles of patients with COPD is also unknown.
OBJECTIVES: (1) To compare NNMT expressions in the diaphragm and quadriceps muscles of patients with COPD. (2) To identify the influence of proinflammatory cytokines on NNMT expression. (3) To assess the influence of NNMT on indices of myogenesis (satellite cell migration and proliferation) and the defense against oxidative stress.
METHODS: Costal diaphragm muscle biopsies were acquired from 13 patients with moderate and severe COPD and 8 control subjects. Quadriceps muscle biopsies were obtained from 12 patients with COPD and 14 control subjects.
MEASUREMENTS AND MAIN RESULTS: NNMT expressions were significantly elevated in the diaphragm and quadriceps muscles of patients with COPD; however, the relative induction of NNMT expression was greater in the quadriceps muscle (10-fold) than it was in the diaphragm (2-fold). NNMT expressions correlated negatively with the severity of COPD and limb muscle wasting. In skeletal myoblasts, NNMT expression was significantly induced by IL-6, transforming growth factor beta, and tumor necrosis factor-alpha. Overexpression of NNMT in myoblasts triggered a significant increase in proliferation and migration, but had no influence on cell death. Carbonyl formation, induced by exposing myoblasts to H(2)O(2), was significantly attenuated when NNMT was overexpressed.
CONCLUSIONS: Up-regulation of NNMT expression in the skeletal muscles of patients with COPD may represent an adaptive response designed to improve myogenesis and defend against oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110558     DOI: 10.1164/rccm.200906-0936OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

Review 1.  Update in chronic obstructive pulmonary disease in 2010.

Authors:  Meilan K Han
Journal:  Am J Respir Crit Care Med       Date:  2011-05-15       Impact factor: 21.405

2.  Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.

Authors:  Nobuhito Taniki; Nobuhiro Nakamoto; Po-Sung Chu; Yohei Mikami; Takeru Amiya; Toshiaki Teratani; Takahiro Suzuki; Tomoya Tsukimi; Shinji Fukuda; Akihiro Yamaguchi; Shunsuke Shiba; Rei Miyake; Tadashi Katayama; Hirotoshi Ebinuma; Takanori Kanai
Journal:  JCI Insight       Date:  2018-06-21

Review 3.  Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.

Authors:  Pavlos Pissios
Journal:  Trends Endocrinol Metab       Date:  2017-03-11       Impact factor: 12.015

4.  Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle.

Authors:  Harshini Neelakantan; Camille R Brightwell; Ted G Graber; Rosario Maroto; Hua-Yu Leo Wang; Stanton F McHardy; John Papaconstantinou; Christopher S Fry; Stanley J Watowich
Journal:  Biochem Pharmacol       Date:  2019-02-10       Impact factor: 5.858

5.  Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD.

Authors:  Santiyagu M Savarimuthu Francis; Jill E Larsen; Sandra J Pavey; Edwina E Duhig; Belinda E Clarke; Rayleen V Bowman; Nick K Hayward; Kwun M Fong; Ian A Yang
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

6.  RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells.

Authors:  Valentina Pozzi; Davide Sartini; Stefano Morganti; Rachela Giuliante; Giulia Di Ruscio; Andrea Santarelli; Romina Rocchetti; Corrado Rubini; Marco Tomasetti; Giovanni Giannatempo; Fiorenza Orlando; Mauro Provinciali; Lorenzo Lo Muzio; Monica Emanuelli
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

7.  Nicotinamide N-methyltransferase is overexpressed in prostate cancer and correlates with prolonged progression-free and overall survival times.

Authors:  Weimin Zhou; Ming Gui; Min Zhu; Zhi Long; Lihua Huang; Jun Zhou; Leye He; Kuangbiao Zhong
Journal:  Oncol Lett       Date:  2014-06-26       Impact factor: 2.967

8.  Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.

Authors:  Andrzej Fedorowicz; Łukasz Mateuszuk; Grzegorz Kopec; Tomasz Skórka; Barbara Kutryb-Zając; Agnieszka Zakrzewska; Maria Walczak; Andrzej Jakubowski; Magdalena Łomnicka; Ewa Słomińska; Stefan Chlopicki
Journal:  Respir Res       Date:  2016-08-31

9.  Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Authors:  Lingling Wang; Yufu Tang; Shuo Liu; Shitao Mao; Yuan Ling; Dan Liu; Xiaoyu He; Xiaoge Wang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling.

Authors:  M G Thomas; M Saldanha; R J Mistry; D T Dexter; D B Ramsden; R B Parsons
Journal:  Cell Death Dis       Date:  2013-06-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.